Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick.
Hims and other telehealth firms make finasteride easy to get and don’t have to disclose side effects in ads.
Kalkine Media22h
Is Hims & Hers Health (NYSE:HIMS) Seeing Increased Institutional...
Highlights,Several financial firms, including Keybank National Association OH, have acquired new stakes in Hims & Hers Health.,Institutional market participation continues to shape financial activity ...
FDA update could extend Hims & Hers’ compounding timeline, says BofA
BofA analyst Allen Lutz notes that the Food and Drug Administration yesterday provided updated enforcement timelines for semaglutide and ...
Hims & Hers to shut down dermatology business Apostrophe
Apostrophe is being shut down to "simplify its (company's) dermatology products and operations into one seamless experience," ...
Hims and Hers bought a skincare startup for $190 million 4 years ago. Today they shut it down.
Hims and Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public ...